• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性膜性肾病患者肾脏结局的动态在线列线图预测模型。

A dynamic online nomogram for predicting renal outcomes of idiopathic membranous nephropathy.

机构信息

Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.

Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.

出版信息

BMC Med Inform Decis Mak. 2024 Jun 19;24(1):173. doi: 10.1186/s12911-024-02568-2.

DOI:10.1186/s12911-024-02568-2
PMID:38898472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11186104/
Abstract

BACKGROUND

Because spontaneous remission is common in IMN, and there are adverse effects of immunosuppressive therapy, it is important to assess the risk of progressive loss of renal function before deciding whether and when to initiate immunosuppressive therapy. Therefore, this study aimed to establish a risk prediction model to predict patient prognosis and treatment response to help clinicians evaluate patient prognosis and decide on the best treatment regimen.

METHODS

From September 2019 to December 2020, a total of 232 newly diagnosed IMN patients from three hospitals in Liaoning Province were enrolled. Logistic regression analysis selected the risk factors affecting the prognosis, and a dynamic online nomogram prognostic model was constructed based on extreme gradient boost, random forest, logistic regression machine learning algorithms. Receiver operating characteristic and calibration curves and decision curve analysis were utilized to assess the performance and clinical utility of the developed model.

RESULTS

A total of 130 patients were in the training cohort and 102 patients in the validation cohort. Logistic regression analysis identified four risk factors: course ≥ 6 months, UTP, D-dimer and sPLA2R-Ab. The random forest algorithm showed the best performance with the highest AUROC (0.869). The nomogram had excellent discrimination ability, calibration ability and clinical practicability in both the training cohort and the validation cohort.

CONCLUSIONS

The dynamic online nomogram model can effectively assess the prognosis and treatment response of IMN patients. This will help clinicians assess the patient's prognosis more accurately, communicate with the patient in advance, and jointly select the most appropriate treatment plan.

摘要

背景

由于特发性膜性肾病(IMN)常自发缓解,免疫抑制治疗存在不良反应,因此在决定是否及何时开始免疫抑制治疗前,评估肾功能进行性丧失的风险非常重要。为此,本研究旨在建立风险预测模型,以预测患者的预后和治疗反应,帮助临床医生评估患者的预后并选择最佳治疗方案。

方法

本研究纳入了 2019 年 9 月至 2020 年 12 月来自辽宁省 3 家医院的 232 例新诊断的 IMN 患者。采用逻辑回归分析筛选影响预后的风险因素,并基于极端梯度提升、随机森林、逻辑回归机器学习算法构建动态在线列线图预测模型。采用受试者工作特征曲线和校准曲线以及决策曲线分析评估模型的性能和临床实用性。

结果

共纳入 130 例患者进入训练队列,102 例患者进入验证队列。逻辑回归分析确定了 4 个风险因素:病程≥6 个月、尿蛋白总量(UTP)、D-二聚体和 sPLA2R-Ab。随机森林算法的 AUC 最高(0.869),表现出最佳性能。该列线图在训练队列和验证队列中均具有良好的判别能力、校准能力和临床实用性。

结论

动态在线列线图模型可有效评估 IMN 患者的预后和治疗反应。这将有助于临床医生更准确地评估患者的预后,与患者提前沟通,并共同选择最合适的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/ceb7c046c623/12911_2024_2568_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/0d891d952110/12911_2024_2568_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/ab6079e21769/12911_2024_2568_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/9d1e17987584/12911_2024_2568_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/41b06ecc7732/12911_2024_2568_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/a192e9c08fee/12911_2024_2568_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/0737eda1900d/12911_2024_2568_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/ceb7c046c623/12911_2024_2568_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/0d891d952110/12911_2024_2568_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/ab6079e21769/12911_2024_2568_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/9d1e17987584/12911_2024_2568_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/41b06ecc7732/12911_2024_2568_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/a192e9c08fee/12911_2024_2568_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/0737eda1900d/12911_2024_2568_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3561/11186104/ceb7c046c623/12911_2024_2568_Fig7_HTML.jpg

相似文献

1
A dynamic online nomogram for predicting renal outcomes of idiopathic membranous nephropathy.特发性膜性肾病患者肾脏结局的动态在线列线图预测模型。
BMC Med Inform Decis Mak. 2024 Jun 19;24(1):173. doi: 10.1186/s12911-024-02568-2.
2
Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.机器学习模型估算特发性膜性肾病患者缓解的概率。
Int Immunopharmacol. 2023 Dec;125(Pt A):111126. doi: 10.1016/j.intimp.2023.111126. Epub 2023 Oct 30.
3
Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome.预测原发性膜性肾病肾病综合征患者病情进展的列线图。
Int Urol Nephrol. 2022 Feb;54(2):331-341. doi: 10.1007/s11255-021-02859-x. Epub 2021 Apr 28.
4
A Dynamic Prediction Model for Renal Progression in Primary Membranous Nephropathy.原发性膜性肾病肾功能进展的动态预测模型。
Int J Med Sci. 2024 May 13;21(7):1292-1301. doi: 10.7150/ijms.95321. eCollection 2024.
5
Prognostic prediction of idiopathic membranous nephropathy using interpretable machine learning.使用可解释的机器学习对特发性膜性肾病进行预后预测。
Ren Fail. 2023;45(2):2251597. doi: 10.1080/0886022X.2023.2251597. Epub 2023 Sep 19.
6
Prediction model for treatment response of primary membranous nephropathy with nephrotic syndrome.原发性膜性肾病肾病综合征治疗反应预测模型。
Clin Exp Nephrol. 2024 Aug;28(8):740-750. doi: 10.1007/s10157-024-02470-1. Epub 2024 May 6.
7
Risk factor analysis and nomogram for predicting poor symptom control in smoking asthmatics.吸烟哮喘患者症状控制不佳的风险因素分析和列线图预测。
BMC Pulm Med. 2024 Jun 1;24(1):264. doi: 10.1186/s12890-024-03076-9.
8
Development and validation of machine learning models and nomograms for predicting the surgical difficulty of laparoscopic resection in rectal cancer.开发和验证用于预测直肠癌腹腔镜切除手术难度的机器学习模型和列线图。
World J Surg Oncol. 2024 Apr 25;22(1):111. doi: 10.1186/s12957-024-03389-3.
9
Construction and validation of a nomogram for predicting remission of migraine patients with patent foramen ovale after closure.卵圆孔未闭偏头痛患者封堵术后缓解预测列线图的构建与验证。
Int J Cardiol. 2024 Jul 15;407:132026. doi: 10.1016/j.ijcard.2024.132026. Epub 2024 Apr 10.
10
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.

引用本文的文献

1
Telitacicept monotherapy for refractory idiopathic membranous nephropathy: a case report and literature review.泰它西普单药治疗难治性特发性膜性肾病:一例病例报告及文献综述
Front Med (Lausanne). 2025 Apr 8;12:1571616. doi: 10.3389/fmed.2025.1571616. eCollection 2025.

本文引用的文献

1
Thromboembolism in nephrotic syndrome: controversies and uncertainties.肾病综合征中的血栓栓塞:争议与不确定性。
Res Pract Thromb Haemost. 2023 Aug 9;7(6):102162. doi: 10.1016/j.rpth.2023.102162. eCollection 2023 Aug.
2
The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy.抗 PLA2R 抗体水平在原发性膜性肾病中的预后价值。
Int J Mol Sci. 2023 May 21;24(10):9051. doi: 10.3390/ijms24109051.
3
A preliminary nomogram model for predicting relapse of patients with primary membranous nephropathy.
原发性膜性肾病患者复发的初步列线图模型。
Ren Fail. 2023 Dec;45(1):2199092. doi: 10.1080/0886022X.2023.2199092.
4
The Value of Peripheral Blood Cell Ratios in Primary Membranous Nephropathy: A Single Center Retrospective Study.外周血细胞比例在原发性膜性肾病中的价值:一项单中心回顾性研究
J Inflamm Res. 2023 Mar 9;16:1017-1025. doi: 10.2147/JIR.S404591. eCollection 2023.
5
Systemic immune inflammation index and pan-immune inflammation value as prognostic markers in patients with idiopathic low and moderate risk membranous nephropathy.系统性免疫炎症指数和全免疫炎症值作为特发性低危和中危膜性肾病患者的预后标志物。
Eur Rev Med Pharmacol Sci. 2023 Jan;27(2):642-648. doi: 10.26355/eurrev_202301_31065.
6
Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis.磷脂酶 A2 受体抗体与特发性膜性肾病患者的临床预后:一项更新的系统评价和荟萃分析。
Kidney Blood Press Res. 2023;48(1):102-113. doi: 10.1159/000529415. Epub 2023 Jan 31.
7
The Mechanistic Role of Different Mediators in the Pathophysiology of Nephropathy: A Review.不同介质在肾病病理生理学中的作用机制:综述
Curr Drug Targets. 2023;24(2):104-117. doi: 10.2174/1389450124666221026152647.
8
Some Points for the KDIGO 2021 Guideline for Prophylactic Anticoagulation in Membranous Nephropathy: Is It Clear Enough for Us to Follow?2021年KDIGO膜性肾病预防性抗凝指南要点:对我们来说是否足够清晰以便遵循?
Nephron. 2023;147(3-4):193-198. doi: 10.1159/000525913. Epub 2022 Jul 28.
9
Prediction model of renal function recovery for primary membranous nephropathy with acute kidney injury.原发性膜性肾病合并急性肾损伤患者肾功能恢复的预测模型。
BMC Nephrol. 2022 Jul 13;23(1):247. doi: 10.1186/s12882-022-02882-9.
10
The Association Between Serum Complement 4 and Kidney Disease Progression in Idiopathic Membranous Nephropathy: A Multicenter Retrospective Cohort Study.血清补体 4 与特发性膜性肾病肾脏疾病进展的相关性:一项多中心回顾性队列研究。
Front Immunol. 2022 May 30;13:896654. doi: 10.3389/fimmu.2022.896654. eCollection 2022.